Treatment of seborrheic dermatitis

American Family Physician

Volumn 61, Issue 9, 2000, Pages 2703-2710

  Johnson, Betty Anne ^a   Nunley, Julia R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; CLOTRIMAZOLE; COAL TAR; CORTICOSTEROID; DANDREX; DENOREX; DERMA SMOOTHE; DESONIDE; DHS ZINC; FLUOCINOLONE ACETONIDE; HYDROCORTISONE; HYDROCORTISONE ACETATE; IONIL T PLUS; KETOCONAZOLE; MICONAZOLE; NOVACET; PYRITHIONE ZINC; SALICYLIC ACID; SEBULON; SEBUTONE; SELENIUM SULFIDE; SULFACETAMIDE; TERBINAFINE; THERAPLEX Z; UNCLASSIFIED DRUG; ZETAR; ZINCON; ZNP BAR;

ARTICLE; CLINICAL FEATURE; DANDRUFF; DRUG COST; HUMAN; HYGIENE; MALASSEZIA; NEUTROGENA; SEBACEOUS GLAND; SEBORRHEIC DERMATITIS;

DERMATITIS, SEBORRHEIC; HAIR PREPARATIONS; HUMANS;

EID: 0034192866     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Janniger CK, Schwartz RA. Seborrheic dermatitis. Am Fam Physician 1995;52:149-55, 159-60 [published erratum appears in Am Fam Physician 1995;52:782].
2. Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S, et al. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998;196:21-31.
3. Hay RJ, Graham-Brown RA. Dandruff and seborrhoeic dermatitis: causes and management. Clin Exp Dermatol 1997;22:3-6.
4. Parry ME, Sharpe GR. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol 1998;139:254-63.
5. Schaub NA, Drewe J, Sponagel L, Gilli L, Courvoisier S, Gyr N, et al. Is there a relation between risk groups or initial CD4 T cell counts and prevalence of seborrheic dermatitis in HIV-infected patients? Dermatology 1999;198:126-9.
6. Schechtman RC, Midgley G, Hay RJ. HIV disease and Malassezia yeasts: a quantitative study of patients presenting with seborrhoeic dermatitis. Br J Dermatol 1995;133:694-8.
7. Basset-Seguin N, Sotto A, Guillot B, Jourdan J, Guilhou JJ. Zinc status in HIV-infected patients: relation to the presence or absence of seborrheic dermatitis. J Am Acad Dermatol 1998;38:276-8.
8. Cowley NC, Farr PM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol 1990;122:71-6.
9. Wikler JR, Janssen N, Bruynzeel DP, Nieboer C. The effect of UV-light on pityrosporum yeasts: ultrastructural changes and inhibition of growth. Acta Derm Venereol 1990;70:69-71.
10. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol 1995; 132:441-5.
11. Faergemann J, Jones JC, Hettler O, Loria Y. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options. Br J Dermatol 1996;134 suppl 46: 12-5, 38.
12. Habif TP. Clinical dermatology: a color guide to diagnosis and therapy, 3d ed. St. Louis: Mosby, 1996:214.
13. Arndt KA, Bowers KE, Chuttani AR. Manual of dermatologic therapeutics: with essentials of diagnosis, 5th ed. Boston: Little, Brown, 1995:166.
14. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology 1998;196:140-7.